Department of Virology, Paul-Ehrlich-Institut, Langen, Germany.
VPR1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.01097-19. Print 2019 Nov 15.
Attenuated poxviruses like modified vaccinia virus Ankara (MVA) are promising vectors for vaccines against infectious diseases and cancer. However, host innate immune responses interfere with the viral life cycle and also influence the immunogenicity of vaccine vectors. Sterile alpha motif (SAM) domain and histidine-aspartate (HD) domain-containing protein 1 (SAMHD1) is a phosphohydrolase and reduces cellular deoxynucleoside triphosphate (dNTP) concentrations, which impairs poxviral DNA replication in human dendritic cells (DCs). Human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) encode an accessory protein called viral protein X (Vpx) that promotes proteasomal degradation of SAMHD1, leading to a rapid increase in cellular dNTP concentrations. To study the function of SAMHD1 during MVA infection of human DCs, the SIV gene was introduced into the MVA genome (resulting in recombinant MVA-vpx). Infection of human DCs with MVA-vpx led to SAMHD1 protein degradation and enabled MVA-vpx to replicate its DNA genome and to express genes controlled by late promoters. Late gene expression by MVA-vpx might improve its vaccine vector properties; however, type I interferon expression was unexpectedly blocked by Vpx-expressing MVA. MVA-vpx can be used as a tool to study poxvirus-host interactions and vector safety. SAMHD1 is a phosphohydrolase and reduces cellular dNTP concentrations, which impairs poxviral DNA replication. The simian SIV accessory protein Vpx promotes degradation of SAMHD1, leading to increased cellular dNTP concentrations. Vpx addition enables poxviral DNA replication in human dendritic cells (DCs), as well as the expression of viral late proteins, which is normally blocked. SAMHD1 function during modified vaccinia virus Ankara (MVA) infection of human DCs was studied with recombinant MVA-vpx expressing Vpx. Infection of human DCs with MVA-vpx decreased SAMHD1 protein amounts, enabling MVA DNA replication and expression of late viral genes. Unexpectedly, type I interferon expression was blocked after MVA-vpx infection. MVA-vpx might be a good tool to study SAMHD1 depletion during poxviral infections and to provide insights into poxvirus-host interactions.
减毒痘病毒,如改良安卡拉痘苗病毒(MVA),是用于传染病和癌症疫苗的有前途的载体。然而,宿主固有免疫反应会干扰病毒的生命周期,并影响疫苗载体的免疫原性。富含亮氨酸重复序列和 Src 同源结构域 3(LRR-SAM)结构域和组氨酸天冬氨酸(HD)结构域蛋白 1(SAMHD1)是一种磷酸水解酶,可降低细胞脱氧核苷三磷酸(dNTP)浓度,从而损害人类树突状细胞(DC)中的痘病毒 DNA 复制。人免疫缺陷病毒 2 型(HIV-2)和猿猴免疫缺陷病毒(SIV)编码一种称为病毒蛋白 X(Vpx)的辅助蛋白,可促进 SAMHD1 的蛋白酶体降解,导致细胞内 dNTP 浓度迅速增加。为了研究 SAMHD1 在 MVA 感染人类 DC 中的功能,将 SIV 基因引入 MVA 基因组(导致重组 MVA-vpx)。用 MVA-vpx 感染人 DC 会导致 SAMHD1 蛋白降解,并使 MVA-vpx 复制其 DNA 基因组并表达受晚期启动子控制的基因。MVA-vpx 的晚期基因表达可能会改善其疫苗载体特性;然而,表达 Vpx 的 MVA 出人意料地阻断了 I 型干扰素的表达。MVA-vpx 可用作研究痘病毒-宿主相互作用和载体安全性的工具。SAMHD1 是一种磷酸水解酶,可降低细胞 dNTP 浓度,从而损害痘病毒 DNA 复制。猿猴 SIV 辅助蛋白 Vpx 促进 SAMHD1 的降解,导致细胞内 dNTP 浓度增加。Vpx 的添加使人类树突状细胞(DC)中的痘病毒 DNA 复制以及通常被阻断的病毒晚期蛋白的表达成为可能。用表达 Vpx 的重组 MVA-vpx 研究 SAMHD1 在 MVA 感染人类 DC 中的功能。用 MVA-vpx 感染人 DC 会降低 SAMHD1 蛋白的含量,从而使 MVA DNA 复制和晚期病毒基因的表达成为可能。出人意料的是,MVA-vpx 感染后 I 型干扰素的表达被阻断。MVA-vpx 可能是研究痘病毒感染期间 SAMHD1 耗竭的良好工具,并深入了解痘病毒-宿主相互作用。